Spirair, Inc

Spirair, Inc. is a medical device company founded in 2020 and headquartered in South San Francisco, California, specializing in minimally invasive solutions for otolaryngologists (ENTs). The company develops innovative FDA-cleared devices designed to improve patient outcomes in nasal and sinus care. Spirair's product portfolio addresses common ENT conditions including nasal septal deviation and turbinate hypertrophy through bioabsorbable implant technology and mechanical correction approaches. The company's mission centers on providing ENT practitioners with integrated treatment options that enhance patient experience, reduce recovery time, and expand the range of patients eligible for minimally invasive intervention. Led by CEO Ben Bishop and founders James Kintzing, PhD, and Brandon McCutcheon, MD, Spirair is backed by venture capital and focused on advancing the standard of care in nasal and sinus surgery.